---
layout: minimal-medicine
title: Dactinomycin
---

# Dactinomycin
### Generic Name
Dactinomycin

### Usage

Dactinomycin, also known as actinomycin D, is an antineoplastic antibiotic.  Its primary use is in the treatment of various cancers, most notably as part of combination chemotherapy regimens.  Specific cancers where it's used include:

* **Ewing's sarcoma:**  A malignant bone tumor, commonly found in children and young adults. Dactinomycin is a crucial component of multi-phase treatment plans.
* **Wilms' tumor (nephroblastoma):** A kidney cancer that primarily affects children.  Similar to Ewing's sarcoma, it's used in combination with other chemotherapeutic agents.
* **Rhabdomyosarcoma:** A cancer of the soft tissues that originates from muscle cells. Again, it's typically part of a broader treatment strategy involving multiple drugs.
* **Gestational trophoblastic neoplasia (GTN):** A group of rare tumors that develop from placental tissue after pregnancy. Dactinomycin may be used alone or in combination with other drugs, depending on the stage and severity of the GTN.
* **Locally recurrent or locoregional solid malignancies:** In adult patients, dactinomycin can be used palliatively or adjunctively as part of regional perfusion therapy for certain solid tumors.


### Dosage

Dactinomycin dosage is highly individualized and depends significantly on the specific cancer being treated, the patient's age and weight, and the overall treatment regimen.  It's crucial to understand that the following information is for general knowledge and should *never* replace the instructions provided by a healthcare professional.  Dactinomycin is administered intravenously (IV).


**Adult Dosages (Examples - not exhaustive):**

Dosage varies widely depending on the specific regimen (e.g., VAIA, VAC/IE, VAD, DD-4A, EE-4A, EMA-CO, EMA-EP, EP-EMA) used for different cancers.  Examples include:

* **Ewing's sarcoma:** 1250 mcg/m² every 3 weeks for 51 weeks (in one regimen) or other variations within combination therapies.
* **Wilms' tumor:** 45 mcg/kg every 3-6 weeks (in one regimen) or other variations within combination therapies.
* **GTN:** 1.25 mg/m² every 2 weeks (as a single agent in low-risk cases) or other regimens depending on the risk.
* **Regional Perfusion:**  Dosage varies considerably depending on the location and specifics of the procedure.


**Pediatric Dosages (Examples - not exhaustive):**

Similar to adult dosages, pediatric regimens are cancer-specific and depend on the child's weight and the chosen treatment protocol.  Dosages are typically calculated based on body weight (mcg/kg) and administered IV.


**Dosage Adjustments:** Dosage adjustments might be necessary based on factors like liver or kidney function, obesity, and the severity of side effects.  These adjustments are determined by the oncologist based on individual patient needs.

### Side Effects

Dactinomycin, like most chemotherapeutic agents, can cause various side effects. The severity and frequency can vary greatly among individuals.

**Common Side Effects:**

* Nausea and vomiting
* Mucositis (mouth sores)
* Myelosuppression (low blood cell counts leading to increased risk of infection, bleeding, and anemia)
* Alopecia (hair loss)
* Fatigue

**Serious but Less Common Side Effects:**

* Hepatic sinusoidal obstruction syndrome (SOS)
* Severe mucocutaneous reactions (skin and mucous membrane reactions)
* Renal dysfunction
* Stevens-Johnson syndrome
* Toxic epidermal necrolysis
* Secondary malignancies (including leukemia)

**Important Note:**  If you experience any concerning side effects, particularly severe or persistent ones, contact your doctor or healthcare provider immediately.


### How it Works

Dactinomycin is an alkylating agent that works by interfering with DNA replication and RNA transcription. It binds to the DNA double helix, preventing the cells from making necessary proteins and replicating, ultimately leading to cell death. This mechanism of action is particularly effective against rapidly dividing cancer cells.

### Precautions

* **Pregnancy and Breastfeeding:** Dactinomycin is categorized as a pregnancy category D drug, meaning it poses a risk to the developing fetus.  Breastfeeding is not recommended during treatment and for a period afterward.  Women of childbearing age should use effective contraception during treatment.
* **Drug Interactions:** Dactinomycin can interact with other medications, including some vaccines and other chemotherapy drugs. Inform your doctor about all medications, supplements, and herbal remedies you are taking.
* **Hepatic and Renal Impairment:** Patients with liver or kidney disease may require dosage adjustments.
* **Radiation Therapy:** Concurrent radiation therapy may necessitate dose reduction or omission of dactinomycin.
* **Extravasation:**  If the drug leaks out of the vein during intravenous administration (extravasation), it can cause tissue damage. Immediate attention is crucial if this occurs.


### FAQs

* **Q: How is Dactinomycin stored?** A:  Specific storage instructions will be provided by your pharmacist or healthcare provider, but generally it should be stored under refrigeration and protected from light.
* **Q:  Can I take other medications while on Dactinomycin?** A: Discuss all medications with your doctor to avoid potentially dangerous interactions.
* **Q: How long does it take to see results from Dactinomycin treatment?** A: The response to Dactinomycin varies widely depending on the cancer type, treatment regimen and individual patient factors.  It's not a quick-acting treatment.
* **Q: What should I do if I miss a dose?** A:  Contact your doctor or healthcare provider immediately to determine the best course of action. Do not attempt to adjust the dosage yourself.
* **Q: Are there long-term side effects?** A: While some side effects may be temporary, others can persist. Regular follow-up appointments are critical for monitoring long-term health.  The possibility of secondary malignancies exists, although rare.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before starting any medication, including Dactinomycin.  The provided dosage information is not exhaustive and should not be used for self-medication.  Treatment plans are individualized and determined by a medical team.
